Our previous study showed that GDF-15 could enhance the proliferation of fibroblasts and may participate in the progression of myocardial fibrosis [13], and GDF-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation [38]. This evidence concerns the gene EGFR and cardiac hypertrophy.